Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

E.R Pearson, I. Flechtner, P.R. Njolstad PR, et al, for the Neonatal Diabetes International Collaborative Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)467-77
JournalNew England Journal of Medicine
Volume355
DOIs
Publication statusPublished - 2006

Keywords

  • neonatal diabetes
  • Sulphonylureas

Cite this